ALBUQUERQUE (June 11) – In May 2014, the Heart Hospital of New Mexico at Lovelace Medical Center was the only hospital in New Mexico to receive the silver Mission: Lifeline Receiving Center quality achievement award from the American Heart Association for the treatment of patients who suffer severe heart attacks. This is currently the highest recognition in New Mexico.
Additionally, the Heart Hospital is the only accredited Chest Pain Center in Albuquerque, as recognized through the Society of Cardiovascular Patient Care.
Heart Hospital has received the Mission: Lifeline® Silver Receiving Quality Achievement Award for implementing specific quality improvement measures outlined by the American Heart Association.
Each year in the United States, approximately 250,000 people have a STEMI, or ST-segment myocardial infarction, caused by a complete blockage of blood flow to the heart that requires timely treatment. To prevent death, it’s critical to immediately restore blood flow, either by surgically opening the blocked vessel or by giving clot-busting medication.
The American Heart Association’s Mission: Lifeline program helps hospitals, emergency medical services and communities improve response times so people who suffer from a STEMI receive prompt, appropriate treatment. The program’s goal is to streamline systems of care to quickly get heart attack patients from the first 9-1-1 call to hospital treatment.
“Lovelace Medical Center is dedicated to improving the quality of care for our patients who suffer a heart attack, and the American Heart Association’s Mission: Lifeline program is helping us accomplish that goal through internationally respected clinical guidelines,” said Troy Greer, CEO, Lovelace Medical Center. “We are pleased to be recognized for our dedication and achievements in cardiac care, and I am very proud of our team.”
Heart Hospital earned the award by meeting specific criteria and standards of performance for the quick and appropriate treatment of STEMI patients to open the blocked artery. Before patients are discharged, they are started on aggressive risk reduction therapies such as cholesterol-lowering drugs, aspirin, ACE inhibitors and beta-blockers, and they receive smoking cessation counseling if needed. Eligible hospitals must adhere to these measures at a set level for a designated period to receive the awards.